Gürtl Barbara, Kratky Dagmar, Guelly Christian, Zhang Lefeng, Gorkiewicz Gregor, Das Suman Kumar, Tamilarasan Kuppusamy Palaniappan, Hoefler Gerald
Department of Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.
Int J Exp Pathol. 2009 Jun;90(3):338-46. doi: 10.1111/j.1365-2613.2009.00647.x.
In previous experiments, we observed signs of cardiac failure in mice overexpressing lipoprotein lipase (LPL) under the control of a muscle specific promotor and in peroxisome proliferators activated receptor alpha (PPARalpha) knockout mice overexpressing LPL under the control of the same promotor. In our current investigations, we focussed on morphological consequences and changes in mRNA and protein expression in hearts from these animals. mRNA expression was analysed by differential display analysis and Northern blot as well as by cDNA microarray analysis followed by pathway analysis. Protein expression was examined using immunoblot and immunohistochemistry. Fibrosis was determined by chromotrope aniline blue staining for collagen. A distinct increase in the expression of alpha-tubulin mRNA was noted in hearts of all mutant mouse strains compared with the control. This result was paralleled by increased alpha-tubulin protein expression. Using cDNA microarray analysis, we detected an activation of apoptosis, in particular an increase of caspase-3 expression in hearts of mice overexpressing LPL but not in PPARalpha knockout mice overexpressing LPL. This finding was confirmed immunohistochemically. In addition, we identified a distinct interstitial increase in collagen and an increase around blood vessels. In our mouse model, we detect mRNA and protein changes typical for cardiomyopathy even before overt clinical signs of heart failure. In addition, a small but distinct increase in the rate of apoptosis of cardiomyocytes and fibrotic changes contributes to cardiac failure in mice overexpressing LPL, whereas additional deficiency in PPARalpha seems to protect hearts from these effects.
在先前的实验中,我们观察到在肌肉特异性启动子控制下过表达脂蛋白脂肪酶(LPL)的小鼠以及在相同启动子控制下过表达LPL的过氧化物酶体增殖物激活受体α(PPARα)基因敲除小鼠出现心力衰竭的迹象。在我们目前的研究中,我们关注这些动物心脏的形态学后果以及mRNA和蛋白质表达的变化。通过差异显示分析、Northern印迹以及cDNA微阵列分析随后进行通路分析来分析mRNA表达。使用免疫印迹和免疫组织化学检查蛋白质表达。通过铬变素苯胺蓝染色检测胶原蛋白来确定纤维化。与对照相比,在所有突变小鼠品系的心脏中均观察到α-微管蛋白mRNA表达明显增加。这一结果伴随着α-微管蛋白蛋白质表达的增加。使用cDNA微阵列分析,我们检测到凋亡的激活,特别是在过表达LPL的小鼠心脏中caspase-3表达增加,但在过表达LPL的PPARα基因敲除小鼠中未增加。这一发现通过免疫组织化学得到证实。此外,我们发现间质中胶原蛋白明显增加,血管周围也增加。在我们的小鼠模型中,甚至在出现明显的心力衰竭临床症状之前,我们就检测到了心肌病典型的mRNA和蛋白质变化。此外,心肌细胞凋亡率的小幅但明显增加以及纤维化变化导致过表达LPL的小鼠发生心力衰竭,而PPARα的额外缺乏似乎可保护心脏免受这些影响。